ISSUES RELATED TO NANOTECHNOLOGY - Emory University相关问题,埃默里大学纳米技术.pptVIP

ISSUES RELATED TO NANOTECHNOLOGY - Emory University相关问题,埃默里大学纳米技术.ppt

  1. 1、本文档共8页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
ISSUES RELATED TO NANOTECHNOLOGY - Emory University相关问题,埃默里大学纳米技术

ISSUES RELATED TO NANOTECHNOLOGY Legal Issues Patents to have a solid grasp of certain applications the examiner may need an in depth knowledge of engineering, biology and physics -- and the number of researchers in the world with such capabilities are not easy to come by. Michel Hoffmann, 2006 biotechnology pharmaceuticals Patent Applicability: It is generally accepted that the properties of matter and other fundamental scientific discoveries are not patentable. In order to secure a patent, the invention must be any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof.“ Terry K. Tullis, Current Intellectual Property Issues in Nanotechnology, 2004 UCLA J.L. Tech. Notes 12 /notes/2004/12_040809_tullis.php Legal Issues Regulation Nanotechnology is likely to produce a great deal of debate for government regulation; the goal of this debate would be to achieve a balance between comprehensive regulation, focused regulation, and, in some instances, no regulation. Joel Rothstein Wolfson, Social and Ethical Issues in Nanotechnology: Lessons from Biotechnology and Other High Technologies, 22 Biotechnology L. Rep. 376, 384 (2003). Any regulatory extreme may present a risk; on one end, very little regulation may make investors reluctant to support development, on the other hand, too much regulation may lead to undesirable, and avoidable, consequences. Fiedler et al., 3 S. Cal. Interdisc. L.J. at 603. The vast range of devices and products that will likely be produced by nanotechnology companies may require many agencies, such as the Food and Drug Administration, the Environmental Protection Agency, the National Institute of Health, or the Department of Health and Human Services, to either have their own regulatory approach or to develop a coordinated regulatory approach. Wolfson, 22 Biotechnology L. Rep. at 384. Environmental Issues “Grey Goo” At the grossest level, ther

您可能关注的文档

文档评论(0)

wuyoujun92 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档